ONTOLOGY REPORT - ANNOTATIONS
| Term: | lycopene |
|
| Accession: | CHEBI:15948
|
browse the term
|
| Definition: | An acyclic carotene that has formula C40H56. |
| Synonyms: | exact_synonym: | psi,psi-carotene |
| | related_synonym: | (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene; C40H56; CC(C)=CCC\\C(C)=C\\C=C\\C(C)=C\\C=C\\C(C)=C\\C=C\\C=C(C)\\C=C\\C=C(C)\\C=C\\C=C(/C)CCC=C(C)C; InChI=1S/C40H56/c1-33(2)19-13-23-37(7)27-17-31-39(9)29-15-25-35(5)21-11-12-22-36(6)26-16-30-40(10)32-18-28-38(8)24-14-20-34(3)4/h11-12,15-22,25-32H,13-14,23-24H2,1-10H3/b12-11+,25-15+,26-16+,31-17+,32-18+,35-21+,36-22+,37-27+,38-28+,39-29+,40-30+; InChIKey=OAIJSZIZWZSQBC-GYZMGTAESA-N; all-trans-lycopene |
| | alt_id: | CHEBI:14541; CHEBI:26367; CHEBI:43789; CHEBI:6596 |
| | xref_casrn: | 502-65-8 |
| | xref: | Beilstein:1730097 "Beilstein Registry Number"; COMe:MOL000048 "COMe"; ChEMBL:602735 "ChEMBL COMPOUND"; ChemIDplus:502-65-8 "CAS Registry Number"; KEGG COMPOUND:502-65-8 "CAS Registry Number"; KEGG COMPOUND:C05432 "KEGG COMPOUND"; LIPID MAPS:LMPR01070257 "LIPID MAPS instance" |
| | xref_mesh: | MESH:C015329 |
| | xref: | PDBeChem:LYC "PDBeChem" |
|
|
lycopene
|
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Add1 |
adducin 1 (alpha) |
|
decreases expression |
ISO |
14 |
81,750,430 |
81,808,919 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
ISO |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Andpro |
androgen regulated protein |
|
decreases expression |
EXP |
3 |
138,085,660 |
138,092,024 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression |
ISO |
11 |
27,467,207 |
27,500,173 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
increases expression |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
decreases expression |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
decreases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
decreases expression |
ISO |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
decreases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
decreases expression |
ISO |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
decreases expression |
ISO |
3 |
11,672,861 |
11,677,709 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Chga |
chromogranin A (parathyroid secretory protein 1) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
decreases expression |
ISO |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Crb1 |
crumbs homolog 1 (Drosophila) |
|
decreases expression |
ISO |
13 |
52,558,317 |
52,725,099 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
decreases expression |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases activity |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Ddb2 |
damage specific DNA binding protein 2 |
|
increases expression |
ISO |
3 |
75,568,487 |
75,591,428 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
increases expression |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
decreases expression |
ISO |
17 |
7,254,528 |
7,341,500 |
RGD:6480464 |
CTD |
| G |
Fancf |
Fanconi anemia, complementation group F |
|
decreases expression |
ISO |
1 |
101,664,895 |
101,666,720 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja4 |
gap junction protein, alpha 4 |
|
decreases expression |
ISO |
5 |
146,755,061 |
146,757,594 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
decreases expression |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
increases expression |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
decreases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
increases expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kif2a |
kinesin heavy chain member 2A |
|
increases expression |
ISO |
2 |
38,079,564 |
38,143,398 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
increases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
increases expression |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
increases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
decreases expression |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
decreases expression |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
decreases expression |
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases expression |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nup214 |
nucleoporin 214 |
|
decreases expression |
ISO |
3 |
11,079,165 |
11,165,173 |
RGD:6480464 |
CTD |
| G |
P22k15 |
cystatin related protein 2 |
|
decreases expression |
EXP |
3 |
138,329,673 |
138,336,731 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
decreases expression |
ISO |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
decreases expression |
EXP |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
ISO |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
decreases expression |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Psbpc2 |
prostatic steroid-binding protein C2 |
|
decreases expression |
EXP |
1 |
212,121,766 |
212,124,641 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rassf7 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
|
increases expression |
ISO |
1 |
201,411,162 |
201,413,083 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rdx |
radixin |
|
decreases expression |
ISO |
8 |
55,404,000 |
55,450,183 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
decreases expression |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
decreases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Sbp |
spermine binding protein |
|
decreases expression |
EXP |
10 |
13,183,508 |
13,186,889 |
RGD:6480464 |
CTD |
| G |
Scgb1d2 |
secretoglobin, family 1D, member 2 |
|
decreases expression |
EXP |
1 |
212,016,491 |
212,019,480 |
RGD:6480464 |
CTD |
| G |
Scgb2a2 |
secretoglobin, family 2A, member 2 |
|
decreases expression |
EXP |
1 |
212,162,326 |
212,165,105 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
multiple interactions |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Skap2 |
src kinase associated phosphoprotein 2 |
|
decreases expression |
ISO |
4 |
80,149,846 |
80,300,111 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
increases expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smc1a |
structural maintenance of chromosomes 1A |
|
decreases expression |
ISO |
X |
41,503,393 |
41,547,830 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
decreases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
decreases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
multiple interactions |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
increases expression |
ISO |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Wrb |
tryptophan rich basic protein |
|
decreases expression |
ISO |
11 |
36,453,285 |
36,467,217 |
RGD:6480464 |
CTD |
Term paths to the root
|